Sensitization of Human Carcinoma of Nasopharynx Cells to Doxorubicin and Induction of Apoptosis by Sargassum baccularia Lipophilic Fraction

The pharmaceutical properties of marine bioactive compounds derived from variants of the Sargassum species have long been recognized as important features for medicinal use. However, the molecular mechanisms of their anticancer activities are unclear. This study aimed to investigate the apoptosis-mo...

Full description

Saved in:

Bibliographic Details
Published in:	Walailak journal of science and technology Vol. 12; no. 6; pp. 515 - 525
Main Authors:	Chantarawan SAENGKHAE, Yanee PREMSURIYA, Rattanaporn SRIVIBOOL, Jantana PRAIBOON
Format:	Journal Article
Language:	English
Published:	Walailak University 13-07-2015
Subjects:	apoptosis carcinoma of nasopharynx cells lipophilic fraction Sargassum baccularia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The pharmaceutical properties of marine bioactive compounds derived from variants of the Sargassum species have long been recognized as important features for medicinal use. However, the molecular mechanisms of their anticancer activities are unclear. This study aimed to investigate the apoptosis-modulating activities of Sargassum baccularia lipophilic fraction (SBL fraction) in human carcinoma of nasopharynx cells (KB cells). Sargassum baccularia was extracted with 95 % ethanol and then fractionated through solvent-solvent partitioning with chloroform: methanol: water. It was found that SBL fraction and doxorubicin (Dox) alone inhibited proliferation in KB cells with IC50 of 85.04 ± 5.28 and 2.0 ± 0.1 µg/ml, respectively. The combined SBL fraction (10 - 50 µg/ml) and Dox (1 µg/ml) treatment produced greater cytotoxicity associated with the increasing of chromatin condensation, DNA fragmentation, and hypo-diploid cells (DNA < 2n), compared with each SBL fraction and Dox alone. Apoptosis induced by SBL fraction was associated with caspase-3 activation that was attenuated in a caspase-3 inhibitor. Thus, SBL fraction acts as potent sensitizer for doxorubicin-induced apoptosis, and it can be potentially developed into a promising adjuvant therapy for nasopharynx carcinoma.
ISSN:	1686-3933 2228-835X